CapsoVision (CV) vs LivaNova (LIVN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
CapsoVision (CV) has outperformed LivaNova (LIVN) over the past year, gaining 43.9% versus a gain of 42.2%. LivaNova is the larger company by market cap ($4.20 billion vs $350.7 million), about 12.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CV | LIVN |
|---|---|---|
| Share price | $6.59 | $76.39 |
| Market cap | $350.66M | $4.20B |
| 1-day change | -0.45% | +0.63% |
| YTD return | -38.07% | +23.37% |
| 1-year return | +43.91% | +42.23% |
| 5-year return | — | -9.51% |
| P/E ratio (TTM) | — | 22.60 |
| Forward P/E | — | 16.31 |
| EPS (TTM) | $-0.45 | $3.38 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $1.39B |
| Revenue growth (YoY) | — | +10.74% |
| Net income (latest FY) | — | $-242.47M |
| Gross margin | — | 67.71% |
| Operating margin | — | 14.36% |
| Net margin | — | -17.47% |
| 52-week high | $15.37 | $85.76 |
| 52-week low | $4.38 | $48.82 |
| Distance from 52-week high | -57.12% | -10.93% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +44.16% | +18.54% |
| Average volume | 157.18K | 645.31K |
| Shares outstanding | 53.21M | 54.93M |
| Employees | 99 | 3,300 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- LivaNova is about 12.0 times larger than CapsoVision by market value ($4.20B vs $350.66M).
About CapsoVision
CV stock →CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon).
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 99 employees
About LivaNova
LIVN stock →LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services. The company operates in two segments, Cardiopulmonary and Neuromodulation.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 3,300 employees
CV vs LIVN FAQ
Which is bigger, CapsoVision or LivaNova?
LivaNova (LIVN) is larger, with a market capitalization of $4.20B compared with $350.66M for CapsoVision (CV).
Which stock has performed better over the past year, CV or LIVN?
CV returned +43.91% over the past 12 months, compared with +42.23% for LIVN (price return, excluding dividends). Past performance does not predict future results.
Are CapsoVision and LivaNova in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.